This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
*electronic orders for direct bill customers only, other terms and conditions may apply.
**insurance availability and copayment/coinsurance requirements are based on current government guidance and is subject to revision if/when plan/payor requirements evolve
The COVID-19 Pandemic is a rapidly evolving situation and guidance is updated frequently. Check your destination’s COVID-19 situation BEFORE traveling. Country, State, local, and territorial governments may have specific travel restrictions or requirements in place. It is ultimately the traveling individuals responsibility to confirm their destinations policy.
© 2022 Acupath Laboratories. All rights reserved